News & Events
-
November 10, 2010
Leading Pharmacologist and Pharmaceutical Scientist Joins Critical Path Institute
Thorir D. Bjornsson, MD, PhD, has joined Critical Path Institute as a member of its Board of Directors, and will also lead one of its major consortia, the Critical Path to TB Drug Regimens, Regulatory Science Consortium (CPTR). -
November 10, 2010
Leading Neuroscientist Joins Critical Path Institute
Marc Cantillon, MD, has joined Critical Path Institute as Executive Director of one of its major consortia, the Coalition Against Major Diseases (CAMD). Dr.Cantillon has a 15+year background in government,academic and pharmaceutical industry translational research, drug development and clinical research. -
October 10, 2010
Manuscript on Current State of Pharmacometrics in Special Issue of Journal of Clinical Pharmacology Co-authored by C-Path’s Klaus Romero, MS, MD Recently Released
Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success -
October 10, 2010
Raymond Woosley, MD, PhD, C-Path President/CEO to present keynote address at CDISC North American Exchange November 1-5, 2010 in Baltimore, MD
The CDISC Board of Directors and Dr. Rebecca Kush, President & CEO are pleased to announce three exceptional keynote speakers to introduce this year’s event: Dr. Doug Fridsma, acting director of the Office of Interoperability and Standards in the Office of the National Coordinator for Health Information Technology; Dr. Theresa M. Mullin, Ph.D., Director, Office... -
October 10, 2010
Governor Brewer Awards $2.2 Million in Stimulus Dollars Towards Creation of New Biomedical Research Resource in Arizona
Science Foundation Arizona selects Tucson based Critical Path Institute and collaborator, Roche’s Ventana Medical Systems, to develop innovative national resource for clinical research standardization